- Home
- Mission Statement
- Daily Vaccine News
- Daily News Archive
- Sandy's Column
- Sandy, Other
- Adverse Reactions
- Age of Autism - UPI
- Archived Sections
- Blogs
- Books
- Contact
- Donate
- Hilary and Ginger
- Important Notices
- Medical Journals
- Other Websites
- Political Action
- Privacy Statement
- RedFlags Archive
- State Laws
- Testimonials
- Unconventional Wisdom
- Vaccination Council
- Vaccine Research Library
- Vaccines, Pipeline
- Videos
- Video Archive
"Vaccine Research Shows Resurgence Contributions, Recent Viruses Spark Interest"Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
September 30, 2002
U.S. IMMUNIZATION NEWS
"Vaccine Research Shows Resurgence Contributions, Recent Viruses Spark Interest" Boston Globe (www.boston.com/globe) (09/29/02) P. A14; Smith, Stephen
Vaccine research is booming once again, faced with the daunting new threats of bioterrorism using anthrax, smallpox, plaque, tularemia, and botulism. During the recent Interscience Conference on Antimicrobial Agents and Chemotherapy, researchers announced that progress was ongoing in finding a vaccine against Legionnaires' disease, and they showed how vaccines were slowing the spread rate of childhood meningitis. Biotech companies like Acambis are making enormous progress in developing vaccines; the company is currently in trials of a smallpox vaccine since being awarded a contract from the Centers for Disease Control and Prevention to produce 209 million doses and a $3 million award from the National Institutes of Health is fueling Acambis' research into a vaccine against West Nile virus. One company spokesman said that human tests on the ChimeriVax-West Nile vaccine could begin within six months. Questions remain, however, as to who should get certain vaccines once they are available for distribution. Searching for vaccines is expensive both in time and funding, although recently funding for vaccine research has picked up, coming from government agencies, private companies, and individual philanthropists. ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.
Copyright 2012 by Vaccination News, A Non-Profit Corporation. All Rights Reserved. This content may not be copied unless permission in writing from Sandy Gottstein has been obtained. 
|
 "A foolish faith in authority is the worst enemy of truth." -- Albert Einstein, letter to a friend, 1901 "I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education." -- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820 "What's the point of vaccination if it doesn't protect you from the unvaccinated?" -- Sandy Gottstein "Who gets to decide what the greater good is and how many will be sacrificed to it?" -- Sandy Gottstein |